Global Protein Engineering Market is expected to grow at a CAGR of approximately
6.2% During the Forecast Period of 2020 to 2027:
Market Scenario:
Proteins, the building blocks of the body, are large biomolecules made up of amino acids.
They perform various functions such as DNA replication, catalyzing metabolic reactions,
transporting molecules from one location to another, and responding to stimuli.
Furthermore, proteins also have a wide range of applications in the diagnosis of disease and
treatment development. Protein engineering involves designing and constructing new
proteins by modifying amino acid sequences to produce enzymes and desired properties and
the synthesis of proteins with a particular structure. This technology helps us to understand
the basics of how enzymes function and have evolved, and it is the key method of
improving enzyme properties for applications in pharmaceuticals, green chemistry, and
biofuels.
The major objective of protein engineering is to produce biological compounds which include
a synthetic peptide, storage protein, and synthetic drugs which will be superior to a normal
one and create an enzyme which is superior in its properties to produce high-value
chemicals in large quantities.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/691

The global protein engineering market is driven by the increasing demand for new
technologies having their application in healthcare and by the growth in research and
development activities for improving health outcomes using novel technologies.
Furthermore, the emergence of trends in protein identification and tracking and the
increasing use of protein studies in research activities drive the growth of this market.
However, there are various factors that may hinder the growth of the market such as
expensive instruments used in protein engineering that require huge maintenance and lack
of trained personnel.


Key players

Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp.
(U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo
Fisher Scientific (U.S.), and Waters Corp. (U.S).


Market Segmentation


The global protein engineering market is segmented to the basis of type, method,
application, and end-users.
On the basis of type, the market is segmented into instrument, reagents, and services and
software.
On the basis of method, the market is segmented into rational protein design and directed
evolution.
On the basis of application, the market is segmented into food and detergent industries,
environment applications, medical applications, biopolymer production, and
nanobiotechnology.
On the basis of end-user, the market is segmented into academic research institutes,
pharmaceuticals and biotechnology companies, and contract engineering organizations.
Regional Analysis
Globally, protein engineering market consists of four regions, namely, Americas, Europe,
Asia Pacific, and the Middle East and Africa. North America is the largest market owing to
the concentration of major market players and increase in a number of biotechnology and
pharmaceutical companies. The U.S. is the largest market in North America followed by
Canada. In the U.S., extensive protein engineering technologies and methods and
availability of technologically-advanced devices and instruments for research also drive the
growth of the market.
Europe is the second largest market for protein engineering which is majorly driven by the
increasing demand for protein engineering methods and technologies and the overall growth
of research and development sector in major countries such as Germany, the U.K., and
France. Furthermore, the growth in funding for protein engineering and emphasis on drug
discovery are other factors expected to drive the growth of the market during the review
period.
Asia Pacific shows the fastest growth which is driven by the rising prevalence of lifestyle
diseases such as heart diseases, diabetes, obesity, and others and need for new
technologies with their application in healthcare.
The Middle East and Africa shows a steady but positive growth with an increase in the
demand for new drugs and devices for diagnosis and the treatment of diseases and
improvement in healthcare infrastructure.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/protein-engineering-market-691